<DOC>
	<DOCNO>NCT01979614</DOCNO>
	<brief_summary>This mechanistic study patient coronary artery disease effect Serelaxin micro- macrovascular function .</brief_summary>
	<brief_title>Study Vascular Effects Serelaxin</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<criteria>Male female patient â‰¥18 year age , body weight &lt; 160 kg . Patients proven obstructive coronary artery disease , determine either functional ( e.g . treadmill test ) noninvasive clinical imaging assessment ( e.g . stressecho , PET SPECT myocardial perfusion ) , invasive coronary angiography CT coronary angiography point time patient without mild leave ventricular systolic dysfunction ( LVSD ) Previous treatment serelaxin ( also know : RLX030 , relaxin ) Women childbearing potential , defined woman physiologically capable become pregnant , unless use highly effective method contraception dose study treatment . Current plan dialysis . Impaired renal function screen define estimate glomerular filtration rate ( eGFR ) screen prior treatment &lt; 30 mL/min/1.73 m2 , calculate use simplify Modification Diet Renal Disease ( sMDRD ) equation due potential issue administration GdDTPA use MRI contrast agent . SickSinusSyndrome Current history pulmonary edema , include suspect sepsis . restrictive , constrictive cardiomyopathy ( include restrictive mitral filling pattern see Doppler echocardiographic assessment diastolic function ) Known significant valvular disease ( include follow : severe aortic stenosis [ AVA &lt; 1.0 peak gradient &gt; 50 prior current echocardiogram ] , severe aortic regurgitation , severe mitral stenosis ) . Clinical diagnosis acute coronary syndrome ( ACS ) include unstable angina within 30 day prior screen determine clinical enzymatic criterion Troponin elevation dynamic indicative ACS time screen randomization . Previous myocardial infarction within 3 month screen History Coronary Artery Bypass Graft ( CABG ) surgery Heart failure due significant arrhythmia ( include follow : ventricular tachycardia , bradyarrhythmias ventricular rate &lt; 45 beat per minute second third degree AV block atrial fibrillation/flutter ventricular response &gt; 120 beat per minute ) Any surgical medical condition opinion investigator may place patient high risk his/her participation study ( e.g. , history poor tolerance adenosine 3 vessel coronary disease ) Acute myocarditis hypertrophic obstructive , restrictive , constrictive cardiomyopathy ( include restrictive mitral filling pattern see Doppler echocardiographic assessment diastolic function ) . Other protocol define inclusion/exclusion criterion may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>coronary artery disease</keyword>
</DOC>